{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:04:20Z","timestamp":1789128260101,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.coviro.2022.101207","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T22:34:01Z","timestamp":1644014041000},"page":"101207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Broad neutralizing antibody-based strategies to tackle influenza"],"prefix":"10.1016","volume":"53","author":[{"given":"Xiaoyu","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyang","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2022.101207_bib0005","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(99)01241-6","article-title":"Influenza","volume":"354","author":"Cox","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2022.101207_bib0010","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(17)30129-0","article-title":"Influenza","volume":"390","author":"Paules","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2022.101207_bib0015","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","article-title":"Structure and function analysis of an antibody recognizing all influenza A subtypes","volume":"166","author":"Kallewaard","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2022.101207_bib0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature06531","article-title":"Structure and mechanism of the M2 proton channel of influenza A virus","volume":"451","author":"Schnell","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2022.101207_bib0025","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1128\/jvi.56.2.502-511.1985","article-title":"Characterization of the influenza virus M2 integral membrane protein and expression at the infected-cell surface from cloned cDNA","volume":"56","author":"Zebedee","year":"1985","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2022.101207_bib0030","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2008.06.002","article-title":"Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein","volume":"80","author":"Wang","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2022.101207_bib0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coviro.2017.03.002","article-title":"Tackling influenza with broadly neutralizing antibodies","volume":"24","author":"Corti","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2022.101207_bib0040","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.antiviral.2013.09.018","article-title":"Universal anti-neuraminidase antibody inhibiting all influenza A subtypes","volume":"100","author":"Doyle","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2022.101207_bib0045","first-page":"776","article-title":"Baloxavir Marboxil (Xofluza) for Influenza","volume":"100","author":"Erlich","year":"2019","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.coviro.2022.101207_bib0050","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1586\/14787210.4.5.795","article-title":"Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors","volume":"4","author":"Hurt","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.coviro.2022.101207_bib0055","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.coviro.2016.03.002","article-title":"Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine","volume":"17","author":"Cho","year":"2016","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2022.101207_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104562","article-title":"New antibody-based prevention and treatment options for influenza","volume":"170","author":"Sedeyn","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2022.101207_bib0065","doi-asserted-by":"crossref","first-page":"17040","DOI":"10.1073\/pnas.1212371109","article-title":"Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity","volume":"109","author":"Lee","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2022.101207_bib0070","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature11414","article-title":"Cross-neutralization of influenza A viruses mediated by a single antibody loop","volume":"489","author":"Ekiert","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2022.101207_bib0075","article-title":"Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus","volume":"5","author":"Lee","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2022.101207_bib0080","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.coviro.2022.101207_bib0085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam5752","article-title":"A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses","volume":"9","author":"Shen","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2022.101207_bib0090","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2019.03.048","article-title":"Antibodies to a conserved influenza head interface epitope protect by an IgG subtype-dependent mechanism","volume":"177","author":"Watanabe","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2022.101207_sbref0095","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cell.2019.04.011","article-title":"A site of vulnerability on the influenza virus hemagglutinin head domain trimer interface","volume":"177","author":"Bangaru","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2022.101207_bib0100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1073\/pnas.1715471115","article-title":"Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody","volume":"115","author":"Raymond","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2022.101207_bib0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04704-9","article-title":"A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA","volume":"9","author":"Bangaru","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2022.101207_bib0110","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01035-19","article-title":"Mapping of a novel H3-specific broadly neutralizing monoclonal antibody targeting the hemagglutinin globular head isolated from an elite influenza virus-immunized donor exhibiting serological breadth","volume":"94","author":"Qiu","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2022.101207_bib0115","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.tim.2018.03.005","article-title":"Influenza hemagglutinin protein stability, activation, and pandemic risk","volume":"26","author":"Russell","year":"2018","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.coviro.2022.101207_bib0120","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2022.101207_bib0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2022.101207_bib0130","article-title":"The role of Fc gamma receptors in broad protection against influenza viruses","volume":"6","author":"Thulin","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.coviro.2022.101207_bib0135","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/jvi.67.5.2552-2558.1993","article-title":"A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains","volume":"67","author":"Okuno","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2022.101207_bib0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coviro.2022.101207_bib0145","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.coviro.2022.101207_bib0150","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1128\/JVI.00178-14","article-title":"Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody","volume":"88","author":"Wyrzucki","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2022.101207_bib0155","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13577","article-title":"Human antibody 3E1 targets the HA stem region of H1N1 and H5N6 influenza A viruses","volume":"7","author":"Wang","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2022.101207_bib0160","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.chom.2018.09.010","article-title":"Recurring and adaptable binding motifs in broadly neutralizing antibodies to influenza virus are encoded on the D3-9 segment of the Ig gene","volume":"24","author":"Wu","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2022.101207_bib0165","doi-asserted-by":"crossref","first-page":"13580","DOI":"10.1128\/JVI.02289-14","article-title":"Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin","volume":"88","author":"Tan","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2022.101207_bib0170","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coviro.2022.101207_bib0175","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cell.2016.06.043","article-title":"Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses","volume":"166","author":"Joyce","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2022.101207_bib0180","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coviro.2022.101207_bib0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003150","article-title":"Human monoclonal antibodies broadly neutralizing against influenza B virus","volume":"9","author":"Yasugi","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2022.101207_bib0190","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1146\/annurev-immunol-032712-095916","article-title":"Broadly neutralizing antiviral antibodies","volume":"31","author":"Corti","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coviro.2022.101207_sbref0195","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1126\/science.aaq0620","article-title":"Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin","volume":"362","author":"Laursen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.coviro.2022.101207_bib0200","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/14760584.2018.1516553","article-title":"Effector mechanisms of influenza-specific antibodies: neutralization and beyond","volume":"17","author":"Sicca","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.coviro.2022.101207_bib0205","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbrc.2013.10.041","article-title":"A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains","volume":"441","author":"Doyle","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coviro.2022.101207_sbref0210","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1126\/science.aay0678","article-title":"Broadly protective human antibodies that target the active site of influenza virus neuraminidase","volume":"366","author":"Stadlbauer","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.coviro.2022.101207_bib0215","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.immuni.2020.08.015","article-title":"Human antibodies targeting influenza B virus neuraminidase active site are broadly protective","volume":"53","author":"Madsen","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2022.101207_bib0220","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.chom.2019.10.002","article-title":"Structural basis of protection against H7N9 influenza virus by human anti-N9 neuraminidase antibodies","volume":"26","author":"Zhu","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2022.101207_bib0225","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02315-20","article-title":"Structure-based modification of an anti-neuraminidase human antibody restores protection efficacy against the drifted influenza virus","volume":"11","author":"Jiang","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2022.101207_bib0230","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7114","article-title":"Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers","volume":"6","author":"Wan","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2022.101207_sbref0235","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2018.03.030","article-title":"Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies","volume":"173","author":"Chen","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2022.101207_bib0240","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/jvi.62.8.2762-2772.1988","article-title":"Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions","volume":"62","author":"Zebedee","year":"1988","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2022.101207_bib0245","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1073\/pnas.0911806107","article-title":"Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses","volume":"107","author":"Grandea","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2022.101207_bib0250","article-title":"Matrix protein 2 extracellular domain-specific monoclonal antibodies are an effective and potentially universal treatment for influenza A","volume":"95","author":"Bimler","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2022.101207_bib0255","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nrmicro2613","article-title":"Influenza A viruses: new research developments","volume":"9","author":"Medina","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coviro.2022.101207_bib0260","doi-asserted-by":"crossref","first-page":"E5944","DOI":"10.1073\/pnas.1613225113","article-title":"Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact","volume":"113","author":"Leon","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2022.101207_bib0265","doi-asserted-by":"crossref","first-page":"11931","DOI":"10.1073\/pnas.1609316113","article-title":"Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus","volume":"113","author":"He","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2022.101207_bib0270","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-021-00339-y","article-title":"Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques","volume":"6","author":"McCracken","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.coviro.2022.101207_bib0275","doi-asserted-by":"crossref","first-page":"15194","DOI":"10.1073\/pnas.1821317116","article-title":"Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics","volume":"116","author":"Winarski","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2022.101207_bib0280","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2022.101207_bib0285","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","article-title":"A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial","volume":"27","author":"Nachbagauer","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2022.101207_bib0290","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.coviro.2022.101207_bib0295","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature13764","article-title":"Rapid development of broadly influenza neutralizing antibodies through redundant mutations","volume":"516","author":"Pappas","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2022.101207_bib0300","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.chom.2020.06.003","article-title":"Convergent evolution in breadth of two VH6-1-encoded influenza antibody clonotypes from a single donor","volume":"28","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2022.101207_sbref0305","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.aaz5143","article-title":"Different genetic barriers for resistance to HA stem antibodies in influenza H3 and H1 viruses","volume":"368","author":"Wu","year":"2020","journal-title":"Science"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625722000141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625722000141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:06:32Z","timestamp":1761818792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625722000141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":61,"alternative-id":["S1879625722000141"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2022.101207","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Broad neutralizing antibody-based strategies to tackle influenza","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2022.101207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101207"}}